Improving Healthcare

by Hyman, David

• ISBN13: 9780387257518
• ISBN10: 0387257519
• Format: Hardcover
• Copyright: 2006-03-30
• Publisher: Springer Verlag

Summary

Improving Healthcare: A Dose of Competition systematically examines the American health care system from a competition-oriented perspective. The volume surveys the performance of each major sector of the health care system, and identifies impediments to more effective competition. Improving Healthcare examines such issues as competition v. regulation, public and private sector approaches to health care financing, cross-subsidies, licensure, provider market concentration, financial and clinical integration, payment for performance, quality, pharmacy benefit managers, direct-to-consumer advertising of pharmaceuticals, certificates of need, mandates, unionization, the significance of organizational status (nonprofit v. for-profit), and the role of antitrust and consumer protection in health care. It offers concrete recommendations to improve the quality and cost-effectiveness of the American health care marketplace.

Table of Contents

INTRODUCTION	vii
EXECUTIVE SUMMARY	1	(30)
CHAPTER 1. OVERVIEW/BACKGROUND	31	(46)
CHAPTER 2. INDUSTRY SNAPSHOT AND COMPETITION LAW: PHYSICIANS	77	(44)
CHAPTER 3. INDUSTRY SNAPSHOT: HOSPITALS	121	(42)
CHAPTER 4. COMPETITION LAW: HOSPITALS	163	(50)
CHAPTER 5. INDUSTRY SNAPSHOT: INSURANCE AND OTHER THIRD PARTY PAYMENT PROGRAMS	213	(32)
CHAPTER 6. COMPETITION LAW: INSURERS	245	(34)
CHAPTER 7. INDUSTRY SNAPSHOT AND COMPETITION LAW: PHARMACEUTICALS	279	(24)
CHAPTER 8. MISCELLANEOUS SUBJECTS	303	(22)
APPENDIX A HEARINGS AND WORKSHOP PARTICIPANTS	325	(20)
APPENDIX B PUBLIC COMMENTS	345	(11)
APPENDIX C GLOSSARY OF HEALTH CARE TERMS AND ACRONYMS	356	(5)
APPENDIX D SELECTED FEDERAL STATUTES	361	(4)
APPENDIX E SPEECH ANNOUNCING THE HEARINGS	365	(28)
APPENDIX F FEDERAL REGISTER NOTICE FOR HEARINGS	393	(2)
APPENDIX G COMPREHENSIVE AGENDA FOR HEARINGS	395	(22)
APPENDIX H FTC PRESS RELEASE FOR REPORT ISSUANCE	417	(4)
APPENDIX I INTERVIEW OF FTC CHAIRMAN T.J. MURIS IN HEALTH AFFAIRS	421